TY - JOUR
T1 - Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls
AU - Ankarberg-Lindgren, Carina
AU - Elfving, Maria
AU - Albertsson Wikland, Kerstin
AU - Norjavaara, Ensio
PY - 2001
Y1 - 2001
N2 - The objective of pubertal induction in children with hypogonadism is to mimic spontaneous puberty in terms of physical and psychological development. In a clinical observation study, we induced puberty in 15 girls with hyper- or hypogonadotropic hypogonadism using low doses of transdermal estradiol patches attached only during the night and compared the estradiol concentrations obtained with those in healthy girls. Pubertal induction was started between the ages of 12.3 and 18.1 yr. A transdermal matrix patch of 17 beta -estradiol (25 mug/24 h; Evorel, Janssen Pharmaceuticals-Cilag) was cut into pieces corresponding to 3.1, 4.2, or 6.2 mug/24 h initially and attached to the buttock. After 4-14 months, the dose was increased gradually. Serum 17 beta -estradiol concentrations were measured every 2 h by RIA (detection limit, 6.0 pmol/L; 1.6 pg/mL). The results show that it is possible to mimic the spontaneous levels as well as the diurnal pattern of serum 17 beta -estradiol in early puberty, by cutting a transdermal 17 beta -estradiol matrix patch and attaching a part of it, corresponding to 0.08-0.12 pg estradiol/kg BW, to the buttock nocturnally. In most of the girls, breast development occurred within 3- 6 months of the start of treatment.
AB - The objective of pubertal induction in children with hypogonadism is to mimic spontaneous puberty in terms of physical and psychological development. In a clinical observation study, we induced puberty in 15 girls with hyper- or hypogonadotropic hypogonadism using low doses of transdermal estradiol patches attached only during the night and compared the estradiol concentrations obtained with those in healthy girls. Pubertal induction was started between the ages of 12.3 and 18.1 yr. A transdermal matrix patch of 17 beta -estradiol (25 mug/24 h; Evorel, Janssen Pharmaceuticals-Cilag) was cut into pieces corresponding to 3.1, 4.2, or 6.2 mug/24 h initially and attached to the buttock. After 4-14 months, the dose was increased gradually. Serum 17 beta -estradiol concentrations were measured every 2 h by RIA (detection limit, 6.0 pmol/L; 1.6 pg/mL). The results show that it is possible to mimic the spontaneous levels as well as the diurnal pattern of serum 17 beta -estradiol in early puberty, by cutting a transdermal 17 beta -estradiol matrix patch and attaching a part of it, corresponding to 0.08-0.12 pg estradiol/kg BW, to the buttock nocturnally. In most of the girls, breast development occurred within 3- 6 months of the start of treatment.
M3 - Article
SN - 1945-7197
VL - 86
SP - 3039
EP - 3044
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 7
ER -